<?xml version="1.0" encoding="UTF-8"?>
<p id="para0060">Ribavirin may precipitate hematologic adverse effects of organ transplantation regimen such as immunosuppressive agents (mycophenolate mofetil, azathioprine, mTOR inhibitors), Trimethoprim/sulfamethoxazole, and valganciclovir. These hematologic adverse reactions would also worsen hematologic reactions related to COVID-19. So close patient monitoring is essential.</p>
